VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemes
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
Earnings
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Pharma & Energy
LLY vs NVOJNJ vs PFEXOM vs CVX
Compare Any Stocks...
WatchlistInsider
ScreenerThemes
Earnings
WatchlistInsider
AXON
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist
AXONAxon Enterprise, Inc.
$510.60$41.1B
Overview & Verdict
Overview
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice HistoryTechnical Analysis
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Ownership
Holders
HomeStocksAXONBalance Sheet

Axon Enterprise, Inc. (AXON) Balance Sheet

26Y historyFree accessUpdated daily

The company has shifted toward external financing to fund growth, increasing total debt to $1.8 billion by 2026Q1, resulting in a debt-to-equity ratio of 0.52.

AXON Balance Sheet

Income StatementBalance SheetCash FlowRatios
AnnualQuarterly
MetricTTMDec'25Dec'24Dec'23Dec'22Dec'21Dec'20Dec'19Dec'18Dec'17Dec'16Dec'15Dec'14Dec'13Dec'12Dec'11Dec'10Dec'09Dec'08Dec'07Dec'06Dec'05Dec'04Dec'03Dec'02Dec'01Dec'00
Total Current Assets2.74B3.71B2.3B2.39B1.81B1.11B981.95M619.09M558.15M205.19M177.23M161.41M140.03M96.46M79.05M60.56M82.33M85.89M91.6M96.43M56.12M42.43M60.03M26.37M7.14M7.42M764.79K
Cash & Short-Term Investments718.92M1.71B986.35M1.32B974.69M443.02M561.97M350.78M349.46M81.97M89.07M109.78M81.14M51.37M37.81M26.41M42.68M45.51M49.38M51.3M22.33M16.35M31.96M15.88M3.58M5.64M206.41K
Cash Only458.92M1.2B454.84M598.54M353.68M356.33M155.44M172.25M349.46M75.11M40.65M59.53M48.37M42.27M36.13M21.3M42.68M45.51M46.88M48.8M18.77M16.35M14.76M15.88M3.58M5.64M206.41K
Short-Term Investments260M505.42M531.5M721.99M621.01M86.69M406.52M178.53M06.86M48.41M50.25M32.77M9.1M1.68M5.11M002.5M2.5M3.56M017.2M0000
Accounts Receivable870.34M955.74M915.5M700.19M555.09M501.24M293.15M184.98M144.54M56.06M39.47M27.7M30.73M22.49M18.1M11.78M13.54M15.38M16.79M11.69M10.07M6.04M8.51M5.4M888.14K765.33K312.68K
Days Sales Outstanding110.67125.5160.46163.75170.27211.9157.12127.19125.5959.5253.751.0968.1959.5557.5747.7656.8653.8766.0242.3754.2746.2345.9480.6632.9440.7633.44
Inventory408.01M341.81M265.32M269.86M202.47M108.69M89.96M38.84M33.76M45.47M34.84M15.76M18.32M11.11M10.99M11.48M17.82M15.09M13.47M13.51M9.26M10.28M6.84M3.13M2.33M801.93K221.17K
Days Inventory Outstanding103.45111.25115.13162.74160.2119.39124.0663.4276.31121.39130.1583.09106.277.9985.392.13149.19128.82131.16109.81129.46193.54111.18121.35197.89100.4347.11
Other Current Assets746.86M708.94M130.31M48.34M29.41M20.01M13.37M19.29M7.97M0005.19M7.1M9.4M9.97M6.28M8.45M9.43M15.61M12.3M6.96M11.08M1.43M227.63K114.66K0
Total Non-Current Assets4.32B3.29B2.18B1.02B1.05B578.72M399.07M226.55M161.38M132.92M100.93M68.47M45.34M50.91M37.18M44.59M53.86M52.54M38.42M41.34M63.72M69.91M46.23M5.07M762.95K632.84K274.27K
Property, Plant & Equipment336.44M330.98M247.32M236.69M169.84M138.46M127.8M43.77M37.89M31.17M24M21.85M17.52M19.04M21.95M26.85M35.91M38.67M27.13M23.6M20.84M21.06M14.76M3.95M661.37K560.42K274.27K
Fixed Asset Turnover9.77x8.40x8.42x6.59x7.01x6.24x5.33x12.13x11.09x11.03x11.18x9.06x9.39x7.24x5.23x3.35x2.42x2.70x3.42x4.27x3.25x2.26x4.58x6.20x14.88x12.23x12.44x
Goodwill1.89B1.37B756.84M57.95M44.98M43.59M25.2M25.01M24.98M14.93M10.44M9.6M2.21M2.23M0000000000000
Intangible Assets295.07M196.97M175.16M19.54M12.16M15.47M9.45M12.77M15.94M18.82M15.22M7.59M3.12M3.32M3.32M3.22M3.09M2.77M2.45M1.93M1.53M1.34M1.28M1.12M101.57K00
Long-Term Investments2.05B416.83M332.55M231.73M452.77M114.75M102.39M45.5M00234K8.53M9.3M12.02M00000025.48B27.55B18.07B0000
Other Non-Current Assets619.04M612.49M360.96M241.85M210M139.26M88.45M71.81M82.58M52.24M31.52M7.2M2.47M618K308.55K444.93K944.35K104.81K14.97K9.09M-25.45B-27.52B-18.05B-1.14B-152.68M72.42K0
Total Assets7.07B7B4.47B3.41B2.85B1.69B1.38B845.64M719.54M338.11M278.16M229.88M185.37M147.38M116.24M105.14M136.19M138.43M130.02M137.76M119.84M112.34M106.27M31.44M7.9M8.05M1.04M
Asset Turnover0.44x0.40x0.47x0.46x0.42x0.51x0.49x0.63x0.58x1.02x0.96x0.86x0.89x0.94x0.99x0.86x0.64x0.75x0.71x0.73x0.57x0.42x0.64x0.78x1.25x0.85x3.28x
Asset Growth %204.89%56.45%31.25%19.54%68.93%22.24%63.31%17.52%112.81%21.55%21%24.01%25.78%26.79%10.55%-22.79%-1.62%6.47%-5.62%14.96%6.68%5.71%237.96%297.82%-1.87%675.18%-
Total Current Liabilities1.21B1.47B1.68B761.54M602.65M418.52M256.33M195.57M166.01M107.95M78.04M38.14M31.97M20.58M18.11M16.36M11.95M13.78M10.96M12.47M18.3M7.56M8.54M3.97M1.8M2.46M1.83M
Accounts Payable175.13M139.09M71.95M65.85M59.92M32.22M24.14M25.87M15.16M8.59M10.74M7.33M7.68M6.22M6.22M4.51M4.55M6.36M3.86M7.3M4.55M6.32M8.43M3.52M1.37M1.15M589.95K
Days Payables Outstanding41.1545.2731.2239.7147.4135.3933.2942.2434.2722.9440.1138.6544.5243.6848.2936.2138.1154.2837.5659.3863.68118.87136.99136.73115.81144.56125.66
Short-Term Debt080.55M680.29M0000000087K38K00000019.26K45.21K43.11K4.64K265.22K422.42K1.27M246.75K
Deferred Revenue (Current)2.67B714.71M633.58M492.35M380.44M276.05M166.91M120.84M109.72M74.07M47.28M22.08M15.01M8.03M4.79M3.73M3.27M2.82M2.51M1.69M1.04M561.16K399.42K0000
Other Current Liabilities342.74M535.8M160.87M124.62M6.36M6.54M5.43M3.85M37K1.78M1.77M-87K0000372.14K355.93K312.69K671.58K10.43M666.77K102.17K185.91K15.46K33.01K729.31K
Current Ratio2.27x2.53x1.37x3.14x3.00x2.65x3.83x3.17x3.36x1.90x2.27x4.23x4.38x4.69x4.37x3.70x6.89x6.23x8.36x7.73x3.07x5.61x7.03x6.64x3.96x3.02x0.42x
Quick Ratio1.93x2.29x1.21x2.79x2.66x2.39x3.48x2.97x3.16x1.48x1.82x3.82x3.81x4.15x3.76x3.00x5.40x5.14x7.13x6.65x2.56x4.25x6.23x5.85x2.66x2.70x0.30x
Cash Conversion Cycle172.97191.49244.36286.78283.06295.9247.88148.36167.63157.97143.7595.53129.8693.8794.59103.68167.94128.4159.6292.79120.04120.9120.1365.27115.01-3.37-45.11
Total Non-Current Liabilities2.32B2.29B469.05M1.03B980.76M221.84M148.44M106.58M86.2M62.72M49.24M34.74M24.29M16.91M10.84M6.62M6.67M6.94M6.53M4.65M2.21M916.17K607.86K43.78K85.31K70.29K2.82M
Long-Term Debt1.83B1.83B680.29M677.11M673.97M00-6.79M041K118K81K29K0103.28K000000000002.78M
Capital Lease Obligations133.85M041.38M33.55M37.14M20.44M06.79M0000067K103.28K000011.7K30.97K76.19K03.65K15.49K50.98K43.92K
Deferred Tax Liabilities00001K811K649K354K0001.31M1.47M3.12M2.9M0000000040.12K69.82K19.31K0
Other Non-Current Liabilities496.27M458.4M-613.31M50.31M21.64M14.87M36.57M18.29M11.79M7.8M9.06M3.15M1.09M309K1041.98M2.28M2.26M1.69M4.64M2.18M839.98K607.86K0000
Total Liabilities3.53B3.76B2.15B1.79B1.58B640.36M404.77M302.14M252.22M170.67M127.28M72.88M56.26M37.48M28.95M22.98M18.62M20.72M17.49M17.13M20.51M8.47M9.15M4.02M1.89M2.53M4.66M
Total Debt1.83B1.91B1.4B710.66M711.11M20.44M00041K118K255K96K170K137K000030.95K76.19K119.3K4.64K268.88K437.9K1.32M3.07M
Net Debt1.37B708.52M947.12M112.12M357.43M-335.89M-155.44M-172.25M-349.46M-75.06M-40.53M-59.27M-48.27M-42.1M-35.99M-21.3M-42.68M-45.51M-46.88M-42.77M-18.7M-16.23M-14.75M-15.61M-3.14M-4.32M2.86M
Debt / Equity0.52x0.59x0.60x0.44x0.56x0.02x---0.00x0.00x0.00x0.00x0.00x0.00x----0.00x0.00x0.00x0.00x0.01x0.07x0.24x-
Debt / EBITDA18.86x90.57x13.11x3.98x5.72x----0.00x0.00x0.01x0.00x0.00x0.01x----0.00x0.01x0.04x0.00x0.03x0.71x1.36x39.39x
Net Debt / EBITDA14.12x33.60x8.85x0.63x2.87x---27.49x-9.33x-3.56x-1.13x-1.53x-1.31x-1.22x-1.33x-4.59x-19.88x-12.80x-5.96x-1.87x-1.45x-4.99x-0.48x-1.96x-5.09x-4.46x36.74x
Interest Coverage1.69x1.20x54.75x23.45x---61.91x-----167.55x--------683.46x643.92x20823.05x814.52x9.45x3.13x0.18x
Total Equity3.53B3.24B2.33B1.62B1.27B1.05B976.25M543.5M467.32M167.44M150.89M157M129.11M109.89M87.29M82.17M117.56M117.7M112.53M120.64M99.33M103.87M97.12M27.43M6.01M5.53M-3.62M
Equity Growth %163.43%39.31%44.06%27.38%21.06%7.33%79.63%16.3%179.09%10.97%-3.9%21.61%17.48%25.9%6.23%-30.11%-0.12%4.6%-6.72%21.45%-4.37%6.94%254.11%356.01%8.79%252.84%-
Book Value per Share42.8532.4329.6321.4117.4915.8315.809.068.073.112.822.872.372.031.601.381.881.861.761.841.601.631.560.590.170.15-0.12
Total Shareholders' Equity3.53B3.24B2.33B1.61B1.27B1.05B976.25M543.5M467.32M167.44M150.89M157M129.11M109.89M87.29M82.17M117.56M117.7M112.53M120.64M99.33M103.87M97.12M27.43M6.01M5.53M-3.62M
Common Stock1K1K1K1K1K1K1K1K1K1K1K1K1K1K661652647642638635622619609126000
Retained Earnings1.11B936.67M812.01M434.98M257.02M109.88M169.9M172.26M171.38M123.19M118.28M100.98M81.05M62.67M42.88M27.86M35.19M39.57M39.57M35.93M20.91M25.12M24.3M5.18M723.93K515.03K-6.79M
Treasury Stock00-155.95M-155.95M-155.95M-155.95M-155.95M-155.95M-155.95M-155.95M-155.95M-122.2M-114.64M-92.2M-67.2M-47.21M-14.71M-14.71M-14.71M-2.21M-2.21M00000-1M
Accumulated OCI-11.27M-11.81M-18.18M-10.68M-7.18M-1.32M141K-1.1M-1.51M-1.47M903K83K64K-2K-57.03K-80.96K-35.45K00000000-59.94K-79.92K
Minority Interest000000000000000000000000000

Key Metrics

Growth RegimeAccelerating
ProfitabilityStrained
Balance SheetHealthy
Cash FlowMixed
Top Statement Risk

Goodwill and leverage expansion

Verified Source

Metrics are mathematically derived from official filings.

SEC 10-K (2026Q1)

Asset Base Expansion Through Acquisitions

According to the provided balance sheet data, Axon's total assets have surged from $3.4 billion in 2023Q4 to $7.1 billion by 2026Q1, a trajectory that suggests an aggressive inorganic growth strategy rather than purely organic accumulation of operational capital or retained earnings.

The rapid doubling of the asset base over ten quarters indicates a pivot toward aggressive expansion, likely driven by the integration of acquired entities. Investors should monitor whether this asset growth translates into commensurate long-term returns on invested capital or if it merely inflates the balance sheet with non-productive assets.

Leverage Rising to Fund Growth

As reported in financial statements, Axon's total debt has increased from $710.7 million in 2023Q4 to $1.8 billion in 2026Q1, pushing the debt-to-equity ratio to 0.52, which suggests a shift toward utilizing external financing to support the company's ambitious scaling and acquisition objectives.

While the current leverage remains manageable, the upward trend in debt levels warrants caution given the company's history of volatile cash flow generation. The reliance on debt to fund operations may increase interest rate sensitivity, potentially pressuring future margins if the cost of capital continues to rise.

Goodwill Concentration Risks Emerging

Based on reported figures, goodwill has expanded significantly from $57.9 million in 2023Q4 to $1.9 billion by 2026Q1, representing a substantial portion of the company's $7.1 billion in total assets and signaling a reliance on successful post-acquisition integration to maintain balance sheet integrity.

The concentration of goodwill suggests that a significant portion of the company's valuation is tied to intangible synergies rather than tangible infrastructure. This creates a risk of future impairment charges if the acquired businesses fail to meet the performance expectations that justified their purchase prices.

Liquidity Buffers Remain Sufficiently Robust

As indicated by the most recent quarterly filings, Axon maintains a current ratio of 2.27, which, despite fluctuations from a peak of 3.14 in 2023Q4, suggests the company retains a sufficient liquidity buffer to meet its short-term obligations amidst ongoing operational and acquisition-related cash outflows.

The company's ability to maintain a current ratio above 2.0 provides a necessary cushion against the lumpy nature of municipal contract payments and inventory cycles. However, the variability in cash balances suggests that liquidity management remains highly dependent on the timing of large-scale contract renewals and collections.

AXON — Frequently Asked Questions

Quick answers to the most common questions about buying AXON stock.

What are the total assets of Axon Enterprise, Inc. (AXON)?

As of 2025, Axon Enterprise, Inc. (AXON) had total assets of $7.00B including $3.71B in current assets.

How much debt does Axon Enterprise, Inc. (AXON) have?

Axon Enterprise, Inc. (AXON) carries total debt of $1.91B, offset by $1.71B in cash and short-term investments. Comparing total debt to cash helps evaluate the company's debt burden and net leverage.

What is the book value or shareholders' equity of Axon Enterprise, Inc.?

Axon Enterprise, Inc. (AXON) has total shareholders' equity (book value) of $3.24B ($32.43 book value per share). Book value represents the net worth of the company belonging to common stock holders.

What is Axon Enterprise, Inc.'s current ratio and liquidity?

Axon Enterprise, Inc. (AXON) reported a current ratio of 2.53x. A current ratio above 1.0x indicates that the company has more current assets than current liabilities, suggesting sufficient short-term liquidity.